Background: Postmarketing evaluations have linked myocarditis to SARS-CoV-2 mRNA vaccines. We sought to estimate the incidence of myocarditis after mRNA vaccination against SARS-CoV-2, and to compare ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback